Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

医学 心房颤动 肥厚性心肌病 导管消融 心脏病学 内科学 导管 烧蚀 心肌病 外科 心力衰竭
作者
Jordan M. Prutkin,David S. Owens
出处
期刊:Heart [BMJ]
卷期号:102 (19): 1513-1514 被引量:5
标识
DOI:10.1136/heartjnl-2016-309761
摘要

Atrial fibrillation (AF) is a well-recognised comorbidity in patients with hypertrophic cardiomyopathy (HCM), occurring in about 25% of patients.1 It is associated with increased mortality and worse heart failure symptoms, especially if there is concomitant outflow tract obstruction,2 and can be markedly debilitating in some individuals. The loss of atrial kick can reduce preload and worsen or unmask outflow obstruction, and higher ventricular rates can decrease cardiac outputs by reducing left ventricular (LV) filling time in the setting of diastolic dysfunction and reduced LV compliance. Rhythm control strategies are indicated with symptomatic AF, but the current antiarrhythmic choices are suboptimal. Patients with HCM have a propensity for both atrial and ventricular arrhythmias, and there is little data on the safety of antiarrhythmic therapies in this population. Disopyramide is perhaps the best studied agent and may concurrently help to mitigate outflow obstruction through its negative inotropic properties. However, its use is limited by anticholinergic effects and breakthrough AF is common. Amiodarone is more efficacious, but has well described toxicities and should be used cautiously in young individuals. Sotalol, dofetilide and dronedarone may also be considered, but there is less data supporting their use, and there must be caution in monitoring the QT interval with the first two agents and heart failure symptoms with the latter.3 ,4 In this setting, the use of an AF ablation strategy for rhythm control is quite attractive. HCM may manifest as progressive fibrosis and stiffening and any interventions that can slow AF progression would be beneficial, but evidence for the efficacy of AF ablation in HCM is also lacking. In their Heart publication, Providencia et al report a systematic review and meta-analysis of AF ablation in …
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mutongchen发布了新的文献求助10
2秒前
377发布了新的文献求助10
3秒前
ay发布了新的文献求助20
6秒前
古德猫宁发布了新的文献求助10
6秒前
典雅的芷蕾完成签到,获得积分10
6秒前
8秒前
hg08发布了新的文献求助10
8秒前
8秒前
搁浅完成签到,获得积分10
8秒前
11秒前
377完成签到,获得积分10
11秒前
Kyt发布了新的文献求助10
12秒前
万能图书馆应助Cl1audia采纳,获得10
12秒前
snutcc完成签到,获得积分10
13秒前
漂亮白枫发布了新的文献求助10
13秒前
古德猫宁完成签到,获得积分10
15秒前
7iy完成签到,获得积分10
17秒前
llllhh完成签到,获得积分10
18秒前
善学以致用应助漂亮白枫采纳,获得10
19秒前
20秒前
悟空完成签到,获得积分10
20秒前
Rita发布了新的文献求助10
20秒前
希望天下0贩的0应助Ran采纳,获得10
21秒前
21秒前
完美世界应助呜呜啦啦采纳,获得10
22秒前
Cl1audia完成签到,获得积分10
23秒前
所所应助Fine采纳,获得10
24秒前
CC发布了新的文献求助10
24秒前
眼睛大的傲菡完成签到,获得积分10
26秒前
26秒前
小二郎应助科研通管家采纳,获得10
26秒前
深情安青应助科研通管家采纳,获得10
26秒前
丘比特应助科研通管家采纳,获得10
26秒前
Jasper应助科研通管家采纳,获得10
26秒前
李爱国应助科研通管家采纳,获得30
26秒前
科目三应助科研通管家采纳,获得10
26秒前
26秒前
深情安青应助科研通管家采纳,获得10
26秒前
充电宝应助科研通管家采纳,获得10
27秒前
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989797
求助须知:如何正确求助?哪些是违规求助? 3531910
关于积分的说明 11255394
捐赠科研通 3270563
什么是DOI,文献DOI怎么找? 1805008
邀请新用户注册赠送积分活动 882157
科研通“疑难数据库(出版商)”最低求助积分说明 809190